CIK 0001761918 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Erasca, Inc.
Sign in to watch- Ticker
- ERAS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 831217027
- Phone
- (858) 465-6511
- Business address
- 3115 MERRYFIELD ROW, THIRD FLOOR, SAN DIEGO, CA, 92121
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 10 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-10 | Fuchs Charles S. President, R&D | Grant or award · Stock option (right to buy) | +1,300,000 | 1,300,000 | ||
| 2026-06-26 | Start Valerie Denise Harding Director | Grant or award · Stock option (right to buy) | +29,888 | 29,888 | ||
| 2026-06-26 | LIU JEAN I Director | Grant or award · Stock option (right to buy) | +29,888 | 29,888 | ||
| 2026-06-26 | Multani Pratik S Director | Grant or award · Stock option (right to buy) | +29,888 | 29,888 | ||
| 2026-06-26 | Casdin Alexander W. Director | Grant or award · Stock option (right to buy) | +29,888 | 29,888 | ||
| 2026-06-26 | Hambleton Julie Director | Grant or award · Stock option (right to buy) | +29,888 | 29,888 | ||
| 2026-06-26 | Bristol James Arthur Director | Grant or award · Stock option (right to buy) | +29,888 | 29,888 | ||
| 2026-04-01 | Garner Ebun Chief Legal Officer | Option exercise 10b5-1 | +80,000 | $1.70 | $136K | 105,076 |
| 2026-04-01 | Garner Ebun Chief Legal Officer | Sale 10b5-1 | −80,000 | $16.40 | $1.3M | 25,076 |
| 2026-04-01 | Garner Ebun Chief Legal Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −80,000 | 280,000 | ||
| 2026-03-04 | Morris Shannon Chief Medical Officer | Option exercise 10b5-1 | +20,000 | $1.70 | $34K | 20,000 |
| 2026-03-04 | Morris Shannon Chief Medical Officer | Sale 10b5-1 | −20,000 | $15.04 | $301K | 0 |
| 2026-01-29 | Lim Jonathan E Chairman & CEO | Grant or award · Stock option (right to buy) | +2,000,000 | 2,000,000 | ||
| 2026-01-29 | Chacko David M. CFO and CBO | Grant or award · Stock option (right to buy) | +640,000 | 640,000 | ||
| 2026-01-29 | Morris Shannon Chief Medical Officer | Grant or award · Stock option (right to buy) | +625,000 | 625,000 | ||
| 2026-01-29 | Varney Michael David Director | Grant or award · Stock option (right to buy) | +96,000 | 96,000 | ||
| 2026-01-29 | Garner Ebun General Counsel & Corp. Sec. | Grant or award · Stock option (right to buy) | +560,000 | 560,000 | ||
| 2026-01-07 | Garner Ebun General Counsel & Corp. Sec. | Option exercise 10b5-1 | +120,000 | $1.70 | $204K | 145,076 |
| 2026-01-07 | Garner Ebun General Counsel & Corp. Sec. | Sale 10b5-1 | −120,000 | $5.59 | $671K | 25,076 |
| 2026-01-01 | Bristol James Arthur Director | Grant or award · Stock Option (right to buy) | +37,762 | 37,762 |
Page 1 of 7 · 121 trades